Metagenomi Therapeutics (MGX) Retained Earnings (2023 - 2026)
Metagenomi Therapeutics (MGX) reported Retained Earnings of -$44000.0 for Q1 2026, down 107.09% year-over-year from $621000.0 in Q1 2025, and down 116.92% quarter-over-quarter from $260000.0 in Q4 2025.
Metagenomi Therapeutics (MGX) Retained Earnings (2023 - 2026) Analysis & Trends
Metagenomi Therapeutics (MGX) has 4 years of Retained Earnings data on file, last reported at -$44000.0 in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$44000.0, down 107.09% year-over-year; the trailing twelve-month figure through Mar 2026 was -$44000.0 (down 107.09% YoY), and the FY2025 annual result was $260000.0, up 100.12% from the prior year.
- Retained Earnings retreated to -$44000.0 in Q1 2026 per MGX's latest filing, from $260000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $621000.0 in Q1 2025 and troughed at -$288.3 million in Q3 2025.
- A 4-year average of -$120.6 million and a median of -$157.5 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2025 and 2026: Retained Earnings soared 100.37% in 2025, then plunged 107.09% in 2026.
- A 4-year view of Retained Earnings shows it stood at -$144.9 million in 2023, then slumped by 53.85% to -$223.0 million in 2024, then surged by 100.12% to $260000.0 in 2025, then slumped by 116.92% to -$44000.0 in 2026.
- Business Quant data shows MGX's Retained Earnings at -$44000.0 in Q1 2026, $260000.0 in Q4 2025, and -$288.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | -838.07 Mn |
| 10 | Metagenomi Therapeutics | 42.84 Mn | 42.84 Mn | - | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44,000.00 |
| Dec 31, 2025 | 260,000.00 |
| Sep 30, 2025 | -288.34 Mn |
| Jun 30, 2025 | 372,000.00 |
| Mar 31, 2025 | 621,000.00 |
| Dec 31, 2024 | -223.00 Mn |
| Sep 30, 2024 | -199.60 Mn |
| Jun 30, 2024 | -180.83 Mn |
| Mar 31, 2024 | -170.09 Mn |
| Dec 31, 2023 | -144.94 Mn |